Found 9 matching trials
Phase III Study of Compound Danshen Dripping Pills to Treat Diabetic Retinopathy
PHASE3The purpose of this study is to evaluate the efficacy and safety of Compoun...
Location
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Expanded Access to T89 for Treatment Use in Intermediate-size Patients Population With COVID-19
N/AThis expanded access use program will provide a botanical drug of T89 for t...
Status
No Longer Available
Location
MultiCare Health System
A Study to Evaluate the Effect of T89(Dantonic®)on Steady-State Pharmacodynamics of Warfarin
PHASE1The purpose of this study is to evaluate the potential effect of Dantonic o...
Location
Healthcare Discoveries, LLC d/b/a ICON Development Solutions
Phase III Trial of Dantonic® (T89) Capsule to Prevent and Treat Stable Angina
PHASE3This phase III study is designed as a double blind, randomized, multi-natio...
Location
Cardiology and Medicine Clinic
The Effect of T89 on Improving Oxygen Saturation and Clinical Symptoms in Patients With COVID-19
NAThis is an open-label, randomized, blank-controlled treatment clinical stud...
Location
Multiple Locations
Safety and Efficacy of T89 in the Prevention and Treatment of Adults With Acute Mountain Sickness (AMS)
PHASE3The specific aim of this double blind, randomized phase III trial is to eva...
Location
Hypoxia Research Lab, UCSF Parnassus Campus, S-256
A Study To Evaluate The Effect of T89(Dantonic®)On P450 Enzymes
PHASE1Purpose: This study is to determine the effect of T89(Dantonic®)on P450 enz...
Location
Comprehensive Clinical Development NW Inc.
Dose-Escalate Study to Investigate the Safety and Tolerability of T89 in Japanese
PHASE1The purpose of this study is to see how safe an investigational new drug (T...
Location
California Clinical Trial Medical Group
Phase II Multi-Center Study of T89 to Treat Chronic Stable Angina
PHASE2The purpose of this study is to determine the anti-angina effect and dose r...
Location
Paradigm Clinical, Inc.